Peri-operative allogeneic blood transfusion is associated with poor overall survival in advanced epithelial ovarian Cancer; potential impact of patient blood management on Cancer outcomes-Reference-Cited by-同舟云学术

Peri-operative allogeneic blood transfusion is associated with poor overall survival in advanced epithelial ovarian Cancer; potential impact of patient blood management on Cancer outcomes

Published:2018-11 Issue:2 Volume:151 Page:294-298
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Connor Joseph P.,O'Shea Andrea,McCool Kevin,Sampene Emmanuel,Barroilhet Lisa M.

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference18 articles.

1. Blood transfusion and cancer surgery outcomes: a continued reason for concern;Al-Refaie;Surgery,2012

2. Blood transfusions and prognosis in colorectal cancer: long-term results of a randomized controlled trial;Harlaar;Ann. Surg.,2012

3. The effects of anemia and blood transfusion on patients with stage III-IV ovarian cancer;Altman;Int. J. Gynecol. Cancer,2013

4. Neoadjuvant chemotherapy followed by interval cytoreductive surgery in patients with unresectable, advanced stage epithelial ovarian cancer: a single centre experience;Bilici;Arch. Gynecol. Obstet.,2010

5. The association between allogeneic perioperative blood transfusion on tumour recurrence and survival in patients with advanced ovarian cancer;De Oliveira;Transfus. Med.,2012

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of perioperative transfusions on the oncologic outcomes of patients with ovarian cancer: A population‐based study;Journal of Surgical Oncology;2024-08-27

2. The association of perioperative blood transfusion with survival outcomes after major cancer surgery: a population-based cohort study in South Korea;Surgery Today;2024-01-04

3. The Impact of Perioperative Transfusions on the Oncologic Outcomes of Patients with Ovarian Cancer: A Population-Based Study;2024

4. Clinical and economic benefits of parenteral iron carboxymaltosate in patients with gynecological cancers: A retrospective observational study;Journal of Modern Oncology;2023-12-10

5. Impact of perioperative red blood cell transfusion on the prognosis of patients with epithelial ovarian cancer;Heliyon;2023-12